Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$4.12B |
| 2 |
Gilead Sciences
GILD
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$286M |
| 4 |
Amazon
AMZN
|
+$271M |
| 5 |
Meta Platforms (Facebook)
META
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$762M |
| 2 |
SPDR Gold Trust
GLD
|
+$410M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$400M |
| 4 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$227M |
| 5 |
Synchrony
SYF
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 91.35% |
| 2 | Consumer Staples | 2.31% |
| 3 | Technology | 1.26% |
| 4 | Financials | 1.12% |
| 5 | Healthcare | 1.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3301
State Street SPDR S&P Emerging Asia Pacific ETF
GMF
$432M
| $2.3M | ﹤0.01% |
+27,959
| New | +$2.23M |
|
3302
First Trust Multi Cap Growth AlphaDEX Fund
FAD
$584M
| $2.3M | ﹤0.01% |
43,822
-8,306
| -16% | -$438K |
|
3303
PUT
Edison International
EIX
$27B
| $2.3M | ﹤0.01% |
31,800
-19,500
| -38% | -$1.46M |
|
|
UFS
3304
DELISTED
DOMTAR CORPORATION (New)
UFS
| $2.3M | ﹤0.01% |
61,884
+14,953
| +32% | +$551K |
|
|
CSC
3305
DELISTED
Computer Sciences
CSC
| $2.3M | ﹤0.01% |
44,000
-43,279
| -50% | -$2.09M |
|
3306
CALL
Green Plains
GPRE
$1.03B
| $2.29M | ﹤0.01% |
87,600
+28,400
| +48% | +$663K |
|
3307
CALL
Jack in the Box
JACK
$311M
| $2.29M | ﹤0.01% |
23,900
-93,600
| -80% | -$8.88M |
|
|
HOS
3308
PUT
DELISTED
Hornbeck Offshore Services, Inc.
HOS
| $2.29M | ﹤0.01% |
416,700
+348,500
| +511% | +$2.27M |
|
|
VNET
3309
VNET Group
VNET
$1.86B
| $2.29M | ﹤0.01% |
288,022
-26,732
| -8% | -$247K |
|
3310
PUT
World Acceptance Corp
WRLD
$878M
| $2.29M | ﹤0.01% |
46,700
-12,000
| -20% | -$575K |
|
3311
Tapestry
TPR
$25B
| $2.29M | ﹤0.01% |
62,600
-34,000
| -35% | -$1.35M |
|
3312
State Street SPDR Portfolio S&P 600 Small Cap ETF
SPSM
$16.9B
| $2.29M | ﹤0.01% |
92,850
-141,768
| -60% | -$3.4M |
|
3313
PUT
Novavax
NVAX
$1.53B
| $2.29M | ﹤0.01% |
54,955
+38,080
| +226% | +$4.92M |
|
3314
CALL
Schwab U.S Small- Cap ETF
SCHA
$22.7B
| $2.29M | ﹤0.01% |
158,800
+109,200
| +220% | +$1.55M |
|
3315
CALL
UFP Industries
UFPI
$4.74B
| $2.29M | ﹤0.01% |
69,600
+39,300
| +130% | +$1.36M |
|
3316
CALL
Arthur J. Gallagher & Co
AJG
$68.6B
| $2.28M | ﹤0.01% |
44,900
+16,500
| +58% | +$815K |
|
|
ACHN
3317
CALL
DELISTED
Achillion Pharmaceuticals
ACHN
| $2.28M | ﹤0.01% |
282,000
-144,300
| -34% | -$1.23M |
|
3318
PUT
iShares MSCI ACWI ETF
ACWI
$33.3B
| $2.28M | ﹤0.01% |
38,600
+6,400
| +20% | +$373K |
|
3319
CALL
RenaissanceRe
RNR
$13.7B
| $2.28M | ﹤0.01% |
19,000
+9,600
| +102% | +$1.13M |
|
3320
Alaska Air
ALK
$4.72B
| $2.28M | ﹤0.01% |
34,650
-106,564
| -75% | -$7.01M |
|
3321
Cambria Shareholder Yield ETF
SYLD
$1.03B
| $2.28M | ﹤0.01% |
75,929
+35,518
| +88% | +$1.05M |
|
|
AUO
3322
DELISTED
AU Optronics Corp
AUO
| $2.28M | ﹤0.01% |
625,257
+182,225
| +41% | +$698K |
|
3323
Dillards
DDS
$9.69B
| $2.28M | ﹤0.01% |
36,200
+872
| +2% | +$54.5K |
|
|
CTB
3324
DELISTED
Cooper Tire & Rubber Co.
CTB
| $2.28M | ﹤0.01% |
59,924
+45,824
| +325% | +$1.53M |
|
3325
Sinclair Inc
SBGI
$1.04B
| $2.28M | ﹤0.01% |
78,844
-79,455
| -50% | -$2.3M |
|
Similar funds
Jeff Yass's Q3 2016 Portfolio in Review
As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass's Q3 2016 filing shows 1,347 new, 3,278 increased, 3,435 reduced and 1,488 closed positions. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M. The largest sale was Apple, an estimated $762M.
By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, down from 93% a quarter earlier, followed by Consumer Staples and Technology.
- Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
- Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
- Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
- Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
- Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
- Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
- Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.
Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.